The 3D bioprinting sector has been experiencing rapid growth over the last few years and will continue on pace through the next decade, mainly due to R&D, according to market researchers. HP is partnering with the US Centers for Disease Control (CDC) on a trial programme aimed at tackling super bugs and antibiotic resistance, by printing and testing drugs in a bid to catch and stem the spread of antimicrobial resistant strains. The project will see the creation of an automated manufacturing system that can produce up to 100 million doses per year of various antibiotics.
HP is partnering with the US Centers for Disease Control (CDC) on a trial programme aimed at tackling super bugs and antibiotic resistance, by printing and testing drugs in a bid to catch and stem the spread of antimicrobial resistant strains. The project will see the creation of an automated manufacturing system that can produce up to 100 million doses per year of various antibiotics.